Evidence map›Paper›PMID 11101601›Full record

ArticleJournal of clinical microbiology2000

Characterization of chloramphenicol and florfenicol resistance in Escherichia coli associated with bovine diarrhea.

D G White, C Hudson, J J Maurer, S Ayers, S Zhao, M D Lee, L Bolton, T Foley, J Sherwood

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 212 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. From Metagenomes to Functional Expression of Resistance:Antibiotics (Basel, Switzerland) · 2025
    Article
  5. Characterizing the resistome ofFrontiers in microbiology · 2025
    Article
  6. Article
  7. Article
  8. Antimicrobial resistance in genericThe Canadian veterinary journal = La revue veterinaire canadienne · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

D G WhiteNorth Dakota State University, Fargo, North Dakota, USA. dwhite@cvm.fda.gov
C Hudson
J J Maurer
S Ayers
S Zhao
M D Lee
L Bolton
T Foley
J Sherwood
University of Georgia · USCenter for Veterinary Medicine · USNorth Dakota State University · USAgricultural Research Service · USUnited States Food and Drug Administration · US

Funding

NETWORK TO MONITOR RESISTANCE IN COMMENSAL BACTERIAR01AI022383 · NIAID · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI SALYERS, ABIGAIL A · 1985 to 2010
$3.0M
Conjugal Transfer of Bacteriodes Antibiotic ResistancesR56AI022383 · NIAID · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI GARDNER, JEFFREY F · 2011 to 2011
$359k
NIAID NIH HHS AI22383NIAID NIH HHS R01 AI022383NIAID NIH HHS R56 AI022383
6 · The paper itself

Abstract

Florfenicol, a veterinary fluorinated analog of thiamphenicol, is approved for treatment of bovine respiratory pathogens in the United States. However, florfenicol resistance has recently emerged among veterinary Escherichia coli isolates incriminated in bovine diarrhea. The flo gene, which confers resistance to florfenicol and chloramphenicol, has previously been identified in Photobacterium piscicida and Salmonella enterica serovar Typhimurium DT104. The flo gene product is closely related to the CmlA protein identified in Pseudomonas aeruginosa. The cmlA gene confers nonenzymatic chloramphenicol resistance via an efflux mechanism. Forty-eight E. coli isolates recovered from calves with diarrhea, including 41 that were both chloramphenicol and florfenicol resistant, were assayed for the presence of both flo and cmlA genes. Forty-two of the 44 isolates for which florfenicol MICs were > or =16 microg/ml were positive via PCR for the flo gene. All E. coli isolates for which florfenicol MICs were < or =8 microg/ml were negative for the flo gene (n = 4) Twelve E. coli isolates were positive for cmlA, and chloramphenicol MICs for all 12 were > or =32 microg/ml. Additionally, eight isolates were positive for both flo and cmlA, and both florfenicol and chloramphenicol MICs for these isolates were > or =64 microg/ml. DNA sequence analysis of the E. coli flo gene demonstrated 98% identity to the published GenBank sequences of both serovar Typhimurium flo(St) and P. piscicida pp-flo. The flo gene was identified on high-molecular-weight plasmids of approximately 225 kb among the majority of florfenicol-resistant E. coli isolates. However, not all of the florfenicol-resistant E. coli isolates tested contained the large flo-positive plasmids. This suggests that several of the E. coli isolates may possess a chromosomal flo gene. The E. coli flo gene specifies nonenzymatic cross-resistance to both florfenicol and chloramphenicol, and its presence among bovine E. coli isolates of diverse genetic backgrounds indicates a distribution much wider than previously thought.

Indexed as

AnimalsAnti-Bacterial AgentsCattleCattle DiseasesChloramphenicolDiarrheaDrug Resistance, MicrobialEscherichia coliR FactorsThiamphenicolAnti-Bacterial AgentsChloramphenicolflorfenicolThiamphenicol

Identifiers

PMID11101601
PMCPMC87642
OpenAlexW2136822906

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.